#ForInvestorsToday we announced Galderma’s 2025 full-year results – delivering record performance and continued momentum across our leading dermatology portfolio.Among the highlights:- Net sales surpassed 5 billion USD for the first time, growing 17.7% year-on-year at constant currency- Core EBITDA reached 1.2 billion USD, up 18.9% year-on-year- Broad-based growth across product categories and geographies, with double-digit growth in both the U.S. and International markets- Continued scientific ...

Galderma

Galderma announces the triple approval of its next-generation Restylane® syringe in the EU, the U.S., and Canada.  Developed in collaboration with aesthetic practitioners, the new syringe introduces enhanced ergonomics and improved injection control to support consistent, premium results.  These approvals demonstrate our strong heritage in Injectable Aesthetics, and our continued commitment to driving innovation in the field.  Read more: https://lnkd.in/eVPvwkCr ...

Galderma

“You can’t be a company that wants to make people look better and not think about making people feel better.”Beauty x Medicine is back for Season 2 with a kick-off episode exploring the shared commitment to science-based innovation at Galderma and L’Oréal. Host Flemming Ornskov, MD, MPH and CEO of Galderma speaks to special guest Nicolas HIERONIMUS, CEO of L’Oréal, about the synergistic development of beauty and dermatology.The interconnected progress of both industries is best seen in the long- ...

Galderma